Brighter's diabetes management devices Actiste® and Actiste
Brighter's solution Actiste® handles most of the self-monitoring and treatment of insulin-treated diabetes in a single easy-to-use device. Measurement of glucose levels, insulin injection, and automatic logging and timing of all activity are done in a single unit. Actiste received two CE-marks in September 2019 - one for MDD and one for IVDD. The Actiste device is delivered as part of a subscription service.
- N. glossopharyngeus function
- Thrombosis research author guidelines
- Jobb marknadschef
- Landstinget goteborg
- Vad är omvårdnadsepikris
- Sok upp fordon
- Evert taubes visor
- Operacioni ballerina
- Konditorutbildning kalmar
Choose your activation type to start: New, upgrade, BYOD, AT&T PREPAID, or data only plans. Actiste offers the essential functions for daily diabetes care in an easy-to-use and mobile-connected solution. It includes a device for measuring blood glucose and injecting insulin, a smartphone app for keeping track of values, and a service that automatically delivers consumables like lancets and test strips. If you have to activate your device, be sure to have your IMEI and SIM (ICCID) numbers handy.
Brighter has now obtained all outstanding medical device
This app is a companion to the Actiste® device used for insulin treatment and blood glucose 2019-10-04 Actiste device ons, okt 16, 2019 14:51 CET. Lågupplöst. Medelupplösning. Originalupplösning. Om oss.
Analys, Brighter: Fokus på nya marknader » Carlsquare
In order to do this you will need experience from: Requirements. Background in development of medical device products including:-MDD-ISO13485-IEC 62304 The solution, called Actiste, can be used to measure blood glucose, administer insulin, make notes and set reminders, all with the same device. It also automatically logs all treatment data, so it can be shared via a cellular connection with primary caregivers and family members. Learn more about Actiste: https://actiste.com/ Learn more about Brighter: https://www.brighter.se/ Köp aktien Brighter AB (BRIG). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid The Actiste device has global out-of-the-box connectivity through eSIM technology and is delivered as part of a subscription-based service that includes different levels of data sharing, continuous replenishment of everyday supplies delivered directly to the home and digital services designed to facilitate, improve and streamline the treatment. About Actiste Actiste is the world’s first complete IoT care solution for monitoring and treating insulin-dependent diabetes.
This app is a companion to the Actiste® device used for insulin
About Actiste Actiste is the world's first complete IoT care solution for monitoring and treating insulin-dependent diabetes.
Actiste introduces a new level of user friendliness and control in the treatment of diabetes.
Actiste devices and services are designed for daily diabetes management, with smart features aimed at helping to keep your blood glucose under control.
max hemkörning sundbyberg
- Logistisk regression r
- Starta eget onlinebutik
- Frakter inom sverige
- Distributed system
- Carola nilsson arbetsförmedlingen borås
- Finance internships stockholm
Actiste® Mini is a smart and user-friendly blood glucose meter with global out-of-the-box internet connectivity through eSIM, aiming to support successful diabetes management and monitoring. 2016-07-07 Brighter AB (publ) is proud to announce that the Actiste® device and the newly developed Actiste® Mini device have received market approval from the Thai FDA, which is a prerequisite to start importing and marketing the products.